206 related articles for article (PubMed ID: 26345380)
21. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
22. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
[TBL] [Abstract][Full Text] [Related]
23. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
[TBL] [Abstract][Full Text] [Related]
24. Effects of continuous glucocorticoid infusion on bone metabolism in the rat.
King CS; Weir EC; Gundberg CW; Fox J; Insogna KL
Calcif Tissue Int; 1996 Sep; 59(3):184-91. PubMed ID: 8694896
[TBL] [Abstract][Full Text] [Related]
25. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
26. High-Dose α-Tocopherol Supplementation Does Not Induce Bone Loss in Normal Rats.
Kasai S; Ito A; Shindo K; Toyoshi T; Bando M
PLoS One; 2015; 10(7):e0132059. PubMed ID: 26147575
[TBL] [Abstract][Full Text] [Related]
27. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
Li M; Healy DR; Li Y; Simmons HA; Su M; Jee WS; Shen VW; Thompson DD
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):22-32. PubMed ID: 15615075
[TBL] [Abstract][Full Text] [Related]
28. The effect of levetiracetam on rat bone mineral density, bone structure and biochemical markers of bone metabolism.
Karesova I; Simko J; Fekete S; Zimcikova E; Malakova J; Zivna H; Pavlikova L; Palicka V
Eur J Pharmacol; 2018 Apr; 824():115-119. PubMed ID: 29428468
[TBL] [Abstract][Full Text] [Related]
29. Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats.
Sakai S; Takeda S; Sugimoto M; Shimizu M; Shimonaka Y; Yogo K; Hashimoto J; Bauss F; Endo K
Bone; 2015 Dec; 81():449-458. PubMed ID: 26281770
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
31. [Effect of cyclooxygenase-2 on bone loss in ovariectomized rats].
Guo Y; Zhang CY; Tian Y; DI JM; Qin S
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):458-62. PubMed ID: 22932114
[TBL] [Abstract][Full Text] [Related]
32. Influence of ferutinin on bone metabolism in ovariectomized rats. II: role in recovering osteoporosis.
Ferretti M; Bertoni L; Cavani F; Zavatti M; Resca E; Carnevale G; Benelli A; Zanoli P; Palumbo C
J Anat; 2010 Jul; 217(1):48-56. PubMed ID: 20492429
[TBL] [Abstract][Full Text] [Related]
33. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
[TBL] [Abstract][Full Text] [Related]
34. Effects of stanozolol on bone mineral density and bone biomechanical properties of osteoporotic rats.
Liao JM; Wu T; Li QN; Hu B; Huang LF; Li ZH; Yuan L; Zhong SZ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1117-20. PubMed ID: 14625163
[TBL] [Abstract][Full Text] [Related]
35. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
Wang ML; Massie J; Perry A; Garfin SR; Kim CW
Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
[TBL] [Abstract][Full Text] [Related]
36. Glucagon like peptide 2 has a positive impact on osteoporosis in ovariectomized rats.
Xu B; He Y; Lu Y; Ren W; Shen J; Wu K; Xu K; Wu J; Hu Y
Life Sci; 2019 Jun; 226():47-56. PubMed ID: 30959027
[TBL] [Abstract][Full Text] [Related]
37. [Are there any positive effects of TNF-alpha blockers on bone metabolism?].
Seriolo B; Paolino S; Sulli A; Cutolo M
Reumatismo; 2006; 58(3):199-205. PubMed ID: 17013436
[TBL] [Abstract][Full Text] [Related]
38. Effects of cyclosporin-a on rat skeletal biomechanical properties.
Chen Y; Zheng X; Zou R; Wang J
BMC Musculoskelet Disord; 2011 Oct; 12():240. PubMed ID: 22024110
[TBL] [Abstract][Full Text] [Related]
39. Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats.
Luo Y; Zhang L; Wang WY; Hu QF; Song HP; Su YL; Zhang YZ
Bone; 2013 Aug; 55(2):439-48. PubMed ID: 23500174
[TBL] [Abstract][Full Text] [Related]
40. Effect of epimedium pubescen flavonoid on bone mineral status and bone turnover in male rats chronically exposed to cigarette smoke.
Gao SG; Cheng L; Li KH; Liu WH; Xu M; Jiang W; Wei LC; Zhang FJ; Xiao WF; Xiong YL; Tian J; Zeng C; Sun JP; Xie Q; Lei GH
BMC Musculoskelet Disord; 2012 Jun; 13():105. PubMed ID: 22713117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
